Target intelligence / Profile preview

Treatment adherence behavior

Molecular classification
Other
01

Overview

Treatment adherence behavior refers to the extent to which a patient's actions—such as taking medications, following lifestyle recommendations, or attending therapy sessions—align with the agreed-upon recommendations from a healthcare provider[1][2][5]. The term "adherence" is now preferred over "compliance," as it emphasizes an active, voluntary partnership between patient and provider rather than passive obedience[7][9]. Adherence can be intentional (a conscious choice not to follow treatment) or unintentional (due to forgetfulness or barriers)[1][5]. Poor adherence is common across many conditions and significantly impacts health outcomes. It is not a molecular target but rather a behavioral phenomenon influenced by demographic, psychosocial, economic, and treatment-related factors[4]. Interventions aimed at improving adherence are multifaceted but often have limited impact unless tailored individually. In summary, "treatment adherence behavior" describes patient actions related to following medical advice; it is not itself a molecule or receptor. **Note:** This entry does **not** represent a molecular target such as an enzyme or receptor. It describes human behavioral patterns relevant for therapeutic outcomes but cannot be classified within standard molecular families. Therefore: - **is_target:** false — This is not considered a therapeutic target in the sense of being a molecule that drugs interact with. - **is_incorrect:** true — The entry does not correspond to any specific molecule/receptor/target suitable for drug development; it represents patient behavior instead.

Other names
Medication adherencePatient compliance (historical, less preferred)Adherence behaviorTreatment compliance (less preferred)Concordance (in some UK contexts)
02

Biological functions

Other
03

Disease associations

Other
04

Safety considerations

Non-adherence leads to reduced clinical benefit and increased healthcare costs[1][2][5]Non-adherence is associated with higher rates of hospitalization and mortality, especially in chronic diseases[2][3]

Beyond the preview

Go deeper on Treatment adherence behavior.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Treatment adherence behavior.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call